跳至主要内容
临床试验/CTIS2022-500265-27-00
CTIS2022-500265-27-00招募中1 期

Analgesic effectiveness of capsaicin 8% cutaneous patch for the treatment of chronic postsurgical or post-traumatic neuropathic pain: a randomized placebo controlled study in children aged 12 to 17-y - 29BRC21.0184

Centre Hospitalier Regional Et Universitaire De Brest0 个研究点目标入组 46 人开始时间: 2023年4月21日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

年龄范围
0 至 17(—)
性别
All

入选标准

  • Children aged 12 to 17 years (lower age limit of 12 has been chosen to ensure NPSI full filling), Male or female., Persistent neuropathic pain more than 32 months after surgery or trauma despite treatment following recommendations, Neuropathic pain is defined as a DN4 score equal to or greater than 3/7 or 4/10, and localized in a nerve territory explained by the surgery or the trauma, Treatment, survey and follow up must be realized in an identified investigating center of the study.

排除标准

  • Intellectual deficiency not allowing full filling of NPSI., Insuffisant command of the French language to full fill NPSI and other evaluation tools., Parents’ refusal of consent., Underlying neurological disease., Ongoing neurotoxic treatment., Already treated by capsaicin., Cutaneous lesion on pain area.

研究者

相似试验